Xiaofei Xin

3.3k total citations · 1 hit paper
69 papers, 2.9k citations indexed

About

Xiaofei Xin is a scholar working on Materials Chemistry, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Xiaofei Xin has authored 69 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Materials Chemistry, 18 papers in Molecular Biology and 17 papers in Biomedical Engineering. Recurrent topics in Xiaofei Xin's work include Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (7 papers) and Nanoplatforms for cancer theranostics (7 papers). Xiaofei Xin is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (7 papers) and Nanoplatforms for cancer theranostics (7 papers). Xiaofei Xin collaborates with scholars based in China, United States and Singapore. Xiaofei Xin's co-authors include Wei Ji, Jianfeng Xu, S. H. Tang, Dingxian Jia, Zexiang Shen, Shih-Chen Shi, Jian‐Ping Lang, Shuyuan Shi, Lifang Yin and Shan-Kun Tang and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Xiaofei Xin

62 papers receiving 2.8k citations

Hit Papers

Raman spectra of CuO nanocrystals 1999 2026 2008 2017 1999 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofei Xin China 22 1.4k 819 678 470 419 69 2.9k
Bai‐Wang Sun China 29 1.4k 1.0× 889 1.1× 608 0.9× 346 0.7× 381 0.9× 143 2.8k
Md Abdus Subhan Bangladesh 31 1.0k 0.7× 598 0.7× 301 0.4× 289 0.6× 724 1.7× 90 2.9k
Hongmei Sun China 23 817 0.6× 601 0.7× 524 0.8× 337 0.7× 440 1.1× 78 2.3k
Wen Ma China 25 1.2k 0.8× 716 0.9× 409 0.6× 197 0.4× 386 0.9× 91 2.6k
Hongguang Li China 34 2.2k 1.6× 632 0.8× 444 0.7× 883 1.9× 680 1.6× 198 3.9k
Li‐Min Fu China 30 1.7k 1.2× 505 0.6× 503 0.7× 266 0.6× 240 0.6× 107 2.8k
Han Xu China 24 1.6k 1.1× 1.3k 1.6× 440 0.6× 416 0.9× 395 0.9× 95 2.8k
So‐Hye Cho South Korea 29 1.9k 1.3× 482 0.6× 633 0.9× 828 1.8× 446 1.1× 100 3.7k
Xia Wang China 31 1.1k 0.8× 479 0.6× 716 1.1× 596 1.3× 261 0.6× 137 3.2k
Youfu Wang China 19 2.6k 1.8× 926 1.1× 435 0.6× 186 0.4× 543 1.3× 63 3.5k

Countries citing papers authored by Xiaofei Xin

Since Specialization
Citations

This map shows the geographic impact of Xiaofei Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Xin more than expected).

Fields of papers citing papers by Xiaofei Xin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofei Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Xin. The network helps show where Xiaofei Xin may publish in the future.

Co-authorship network of co-authors of Xiaofei Xin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofei Xin. A scholar is included among the top collaborators of Xiaofei Xin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofei Xin. Xiaofei Xin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Ying, Yong Zhou, Zhi-Yu Duan, et al.. (2025). Topical Therapy in Psoriasis: Clinical Benefits, Advances in Novel Drug Delivery Strategies, and Gene Therapy Regimen. Pharmaceutics. 17(3). 283–283. 6 indexed citations
2.
Chu, Depeng, et al.. (2025). Unveiling the Role of Cesium in Halide Perovskite Single Crystal for Stable and Ultrasensitive X‐Ray Detection. Advanced Functional Materials. 36(21). 2 indexed citations
3.
Xin, Xiaofei, et al.. (2025). Highly Transparent Photochromic Coating with Excellent Dimming Capability Based on B─O─W Coordination Bonding Strategy. Angewandte Chemie International Edition. 64(42). e202513064–e202513064.
4.
Yang, Lei, Jingjing Li, Pengbo Zhao, et al.. (2025). Notch1 siRNA and AMD3100 Ameliorate Metabolic Dysfunction-Associated Steatotic Liver Disease. Biomedicines. 13(2). 486–486.
5.
Xin, Xiaofei, Wanyu Li, Rui Yao, et al.. (2025). Liquid-phase synthesis of Mg-Nb nanocomposites with highly stable hydrogenation/dehydrogenation cycling for hydrogen storage. Journal of Alloys and Compounds. 1040. 183676–183676. 2 indexed citations
6.
Hu, Jun, et al.. (2025). A Novel Bifunctional Transparent Non-covalent Crosslinked Hydrogel for Wearable Sensors and Ion Detection. Analytical Chemistry. 97(47). 25937–25945.
7.
Cai, Yan-Bing, et al.. (2025). Novel Small-Molecule Treatment and Emerging Biological Therapy for Psoriasis. Biomedicines. 13(4). 781–781. 5 indexed citations
9.
Hu, Jun, Jing Xu, Zixun Chen, et al.. (2025). Nanoparticle-assisted DES-catalyzed green and efficient synthesis of versatile hydrogels for degradable wearable sensors. Chemical Engineering Journal. 518. 164636–164636.
10.
Liu, Weining, et al.. (2024). Synthesis of highly transparent and fast-responding photochromic coating by template method with space-limited domains. Chemical Engineering Journal. 500. 156961–156961. 4 indexed citations
11.
Gu, Xiaofei, Ji Liu, Yan Zhao, et al.. (2024). Cascade catalyzed dual-responsive Gold-Ferri “bomb-like” nanoreactors for positive feedback penetrating in sequential targeted triple glioblastoma therapy. Chemical Engineering Journal. 498. 155020–155020. 1 indexed citations
12.
Liu, Lisha, Xiaopeng Han, Xiaofei Xin, et al.. (2024). Bioresponsive nanocomplex integrating cancer-associated fibroblast deactivation and immunogenic chemotherapy for rebuilding immune-excluded tumors. Nanomedicine Nanotechnology Biology and Medicine. 58. 102743–102743. 4 indexed citations
13.
Yang, Xiuyi, Lei Yang, Jinyu Dai, et al.. (2024). Lipid nanoparticle-mediated hepatocyte delivery of siRNA and silibinin in metabolic dysfunction-associated steatotic liver disease. Journal of Controlled Release. 373. 385–398. 10 indexed citations
14.
Xin, Xiaofei, Yuxiang Dong, Virender Kumar, et al.. (2024). Anti-CLL1 liposome loaded with miR-497-5p and venetoclax as a novel therapeutic strategy in acute myeloid leukemia. Molecular Therapy. 32(11). 4058–4074. 4 indexed citations
15.
Liu, Ji, et al.. (2024). Catalytic nanoreactors promote GLUT1-mediated BBB permeation by generating nitric oxide for potentiating glioblastoma ferroptosis. Chemical Engineering Journal. 483. 149233–149233. 2 indexed citations
16.
Zhou, Yong, Lei Yang, Di Wu, et al.. (2023). Topical Delivery of ROS-Responsive Methotrexate Prodrug Nanoassemblies by a Dissolvable Microneedle Patch for Psoriasis Therapy. International Journal of Nanomedicine. Volume 18. 899–915. 36 indexed citations
17.
Xin, Xiaofei, Yong Zhou, Ying Zhu, et al.. (2023). Disease-specific corona mediated co-delivery of MTX and siRNA-TNFα by a polypeptide nanoplatform with antigen-scavenging functions in psoriasis. Journal of Controlled Release. 364. 326–342. 8 indexed citations
18.
Zhang, Kai, Jingjing Li, Xiaofei Xin, et al.. (2021). Dual Targeting of Cancer Cells and MMPs with Self-Assembly Hybrid Nanoparticles for Combination Therapy in Combating Cancer. Pharmaceutics. 13(12). 1990–1990. 15 indexed citations
19.
Xin, Xiaofei, et al.. (2018). Drug-delivering-drug platform-mediated potent protein therapeutics via a non-endo-lysosomal route. Theranostics. 8(13). 3474–3489. 28 indexed citations
20.
Qin, Chao, et al.. (2018). Amorphous Nanosuspensions Aggregated from Paclitaxel–Hemoglobulin Complexes with Enhanced Cytotoxicity. Pharmaceutics. 10(3). 92–92. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026